Publications by authors named "Kenneth Lasseter"

Claim this Profile
E
Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor Antagonist.
Jesse C Nussbaum, Azher Hussain, K Chris Min, Thomas C Marbury, Kenneth Lasseter

J Clin Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Mild and Moderate Hepatic Impairment (Defined by Child-Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics.
Hamim Zahir, Jonathan Greenberg, Ching Hsu, Thomas C Marbury, Kenneth C Lasseter

J Clin Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment.
Daniel A Tatosian, Ka Lai Yee, Zufei Zhang, Kate Mostoller, Erina Paul, Kenneth C Lasseter

Clin Pharmacol Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment.
Marcus-Hillert Schultze-Mosgau, Kenneth C Lasseter, Thomas Marbury, Stephanie Loewen, Kai Riecke

J Clin Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.
Pratik Bhagunde, Francheska Colon-Gonzalez, Yang Liu, Jin Wu, Shiyao Sherrie Xu, Kenneth Lasseter

Br J Clin Pharmacol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Maribavir on P-Glycoprotein and CYP2D6 in Healthy Volunteers.
Ivy H Song, Katarina Ilic, Joseph Murphy, Kenneth Lasseter, Patrick Martin

J Clin Pharmacol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis.
Katie Zomorodi, Dan Chen, Lawrence Lee, Kenneth Lasseter, Thomas Marbury

J Clin Pharmacol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment.
Erik Mogalian, Diana M Brainard, Anu Osinusi, Lisa Moorehead, Bernard Murray, Kenneth Lasseter

Clin Pharmacokinet· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Mirogabalin.
Kenneth Duchin, Giorgio Senaldi, Vance Warren, Thomas Marbury, Kenneth Lasseter

Clin Drug Investig· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment.
William L Marshall, Hwa-Ping Feng, Larissa Wenning, Graigory Garrett, Xiaobi Huang, Kenneth C Lasseter

Eur J Drug Metab Pharmacokinet· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies.
Tomohiro Kusawake, Donna Kowalski, Akitsugu Takada, Kota Kato, Masataka Katashima, Kenneth C Lasseter

Adv Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment.
Thomas C Marbury, Anne Flint, Jacob B Jacobsen, Julie Derving Karsbøl, Kenneth Lasseter

Clin Pharmacokinet· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
.
K Chris Min, Kenneth C Lasseter, Thomas C Marbury, Rebecca E Wrishko, William D Hanley

Int J Clin Pharmacol Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics.
Sauzanne Khalilieh, Ka Lai Yee, Rachael Liu, Li Fan, Rosa I Sanchez, Kenneth C Lasseter

J Clin Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.
Takao Yamazaki, Amit Desai, Ronald Goldwater, David Han, Kenneth C Lasseter

Clin Pharmacol Drug Dev· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults.
Robert Townsend, Albert Dietz, Christine Hale, Shahzad Akhtar, Donna Kowalski, Kenneth Lasseter

Clin Pharmacol Drug Dev· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus.
Eric G Vajda, Douglas Logan, Kenneth Lasseter, Danielle Armas, Diane J Plotkin

Diabetes Obes Metab· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Bioavailabilities of Lisdexamfetamine Dimesylate and D-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink.
James Ermer, Mary Corcoran, Kenneth Lasseter, Patrick T Martin

Ther Drug Monit· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Pharmacodynamics, and Safety of ASP015K (Peficitinib), a New Janus Kinase Inhibitor, in Healthy Subjects.
Ying Jun Cao, Taiji Sawamoto, Udaya Valluri, Kathy Cho, Michaelene Lewand, Kenneth Lasseter

Clin Pharmacol Drug Dev· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies.
Tracey Roberts, John F Kokai-Kun, Olivia Coughlin, Barbara Valero Lopez, Heidi Whalen, Kenneth Lasseter

Clin Drug Investig· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function.
James Ermer, Mary Corcoran, Kenneth Lasseter, Thomas Marbury, Brian Yan

Ther Drug Monit· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial.
Chan R Beals, Radha A Railkar, Andrea K Schaeffer, Yotam Levin, Efrat Kochba, Kenneth Lasseter

Lancet Infect Dis· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of renal and hepatic impairment on the pharmacokinetics of anacetrapib.
Brett Lauring, Xiujiang Susie Li, Yang Liu, Christy Corr, Nicole Lazarus, Kenneth C Lasseter

J Clin Pharmacol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of rifampin on the pharmacokinetics of sirolimus in healthy volunteers.
Michael A Tortorici, Kyle Matschke, Joan M Korth-Bradley, Cliff DiLea, Kenneth C Lasseter

Clin Pharmacol Drug Dev· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the single-dose pharmacokinetics of bilastine in subjects with various degrees of renal insufficiency.
Kenneth C Lasseter, Ander Sologuren, Anna La Noce, Stacy C Dilzer

Clin Drug Investig· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis